Vertex Pharmaceuticals (VRTX) Stock Valuation: P/E Ratio and Intrinsic Value

Is Vertex Pharmaceuticals stock expensive or cheap? This page shows the price-earnings ratio of Vertex Pharmaceuticals for the last fiscal years, the current share price, and beta and volatility as risk measures. Earnings figures come from the company's published filings.

How the Vertex Pharmaceuticals P/E ratio is calculated

The price-earnings ratio divides the share price by earnings per share. On this page the ratio is shown per fiscal year, so you can see whether today's valuation of Vertex Pharmaceuticals is above or below its own history. Beta and volatility indicate how strongly the share moves compared with the overall market.

Frequently asked questions about Vertex Pharmaceuticals

What is the VRTX P/E ratio?

The P/E ratio divides the Vertex Pharmaceuticals share price by earnings per share. This page shows the ratio for each of the last fiscal years, so the current valuation of VRTX can be compared with its own history.

Is Vertex Pharmaceuticals stock overvalued or undervalued?

There is no single answer. A useful check is whether the current P/E of VRTX is above or below its multi-year average and how earnings, margins and revenue are developing. This page shows all of these figures from the published filings.

How can I estimate the intrinsic value of Vertex Pharmaceuticals?

An intrinsic value estimate needs earnings or free cash flow, a growth assumption and a discount rate. This page provides the reported earnings basis, margins and the valuation history of VRTX as the starting point.

More on Vertex Pharmaceuticals

• Vertex Pharmaceuticals stock: revenue, segments and business model
• Vertex Pharmaceuticals quarterly earnings